Featured Research

from universities, journals, and other organizations

Minimally invasive aortic valve replacement advantageous for some very elderly patients

Date:
January 2, 2014
Source:
Society of Thoracic Surgeons
Summary:
Transcatheter aortic valve implantation (TAVI) appears to be an effective alternative to surgical aortic valve replacement (AVR) for the treatment of aortic stenosis in very elderly patients, including those age 85 years and older

Transcatheter aortic valve implantation (TAVI) appears to be an effective alternative to surgical aortic valve replacement (AVR) for the treatment of aortic stenosis in very elderly patients, including those age 85 years and older, according to a study in the January 2014 issue of The Annals of Thoracic Surgery.

With an aging population, the number of patients who require cardiac surgery has increased among both octogenarians (age 80-89 years) and nonagenarians (age ≥90 years); however, nearly one-third of patients with severe symptomatic valve disease are not recommended for surgery due to multiple comorbidities or advanced age.

Mansanori Yamamoto, MD, and Emmanuel Teiger, MD, both from the Centre Hospitalier Universitaire (CHU)-Henri Mondor in Creteil, France, led a group of researchers examining TAVI results in very elderly patients.

“Our study found TAVI to provide acceptable clinical results in very elderly populations,” said Dr. Yamamoto. “Elderly patients generally require more time to recover after invasive treatments, such as AVR, so TAVI may have advantages because earlier mobility plays a significant role in maintaining neuromuscular strength and physical function in elderly patients. Smaller incisions allow faster resumption of physical activity and therefore full recovery.”

For the study, researchers collected data from 2,254 patients age 80 years and older who underwent TAVI between January 2010 and October 2011 at any of the 34 hospitals participating in the French national TAVI registry (FRANCE-2 Registry). For the analysis, patients were divided into three categories based on age: 80-84 years (867 patients), 85-89 years (1,064 patients), and ≥90 years (349 patients).

High procedural success was achieved in every patient age group (97.8%, 96.3%, and 97.1%, respectively), and both length of hospital stay and time in the intensive care unit were similar in all groups.

Cumulative mortality rates for the entire patient population were 9.9% at 30-days and 23.8% at 1-year post-surgery. Mortality rates at 1-year were higher among patients in the 85-89 and ≥90 year age groups, compared with the mortality rate in patients in the 80-84 year age group (26.1%, 27.7%, and 19.8%, respectively).

“TAVI may be a good therapeutic option even in very elderly patients,” said Dr. Teiger.


Story Source:

The above story is based on materials provided by Society of Thoracic Surgeons. Note: Materials may be edited for content and length.


Journal Reference:

  1. Masanori Yamamoto, Gauthier Mouillet, Kentaro Meguro, Martine Gilard, Marc Laskar, Helene Eltchaninoff, Jean Fajadet, Bernard Iung, Patrick Donzeau-Gouge, Pascal Leprince, Alain Leuguerrier, Alain Prat, Michel Lievre, Karine Chevreul, Jean-Luc Dubois-Rande, Emmanuel Teiger. Clinical Results of Transcatheter Aortic Valve Implantation in Octogenarians and Nonagenarians: Insights From the FRANCE-2 Registry. The Annals of Thoracic Surgery, 2013; DOI: 10.1016/j.athoracsur.2013.07.100

Cite This Page:

Society of Thoracic Surgeons. "Minimally invasive aortic valve replacement advantageous for some very elderly patients." ScienceDaily. ScienceDaily, 2 January 2014. <www.sciencedaily.com/releases/2014/01/140102112051.htm>.
Society of Thoracic Surgeons. (2014, January 2). Minimally invasive aortic valve replacement advantageous for some very elderly patients. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2014/01/140102112051.htm
Society of Thoracic Surgeons. "Minimally invasive aortic valve replacement advantageous for some very elderly patients." ScienceDaily. www.sciencedaily.com/releases/2014/01/140102112051.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins